Login / Signup

The risk of worsening of myasthenia by cardiovascular medication as reflected by reporting frequency.

Peter TrillenbergAlexander KatalinicJulia ThernTobias Graf
Published in: European journal of neurology (2021)
Angiotensin receptor antagonists, angiotensin-converting enzyme inhibitors, and diuretics seem to be safe in antihypertensive therapy. Surprisingly, and yet requiring confirmation by case reports, alpha receptor-blocking drugs seem to carry a risk of myasthenia worsening. Amiodarone seems to be a safe alternative in antiarrhythmic therapy in patients with myasthenia.
Keyphrases
  • angiotensin converting enzyme
  • angiotensin ii
  • blood pressure
  • adverse drug
  • healthcare
  • case report
  • emergency department
  • bone marrow
  • cell therapy
  • atrial fibrillation
  • electronic health record
  • chemotherapy induced